Literature DB >> 33682677

PAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: multum non multa.

Izolde Bouloukaki1, Charalampos Mermigkis1, Katerina M Antoniou2, Sophia E Schiza2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33682677      PMCID： PMC8314655          DOI： 10.5664/jcsm.9212

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.324


× No keyword cloud information.
  5 in total

1.  Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.

Authors:  Ganesh Raghu; Steven D Nathan; Juergen Behr; Kevin K Brown; James J Egan; Steven M Kawut; Kevin R Flaherty; Fernando J Martinez; Athol U Wells; Lixin Shao; Huafeng Zhou; Noreen Henig; Javier Szwarcberg; Hunter Gillies; Alan B Montgomery; Thomas G O'Riordan
Journal:  Eur Respir J       Date:  2015-08-06       Impact factor: 16.671

2.  Pulmonary artery hemodynamics are associated with duration of nocturnal desaturation but not apnea-hypopnea index.

Authors:  Bilal Samhouri; Mrinalini Venkatasaburamini; Hugo Paz Y Mar; Manshi Li; Reena Mehra; Neal F Chaisson
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

3.  Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis.

Authors:  Charalampos Mermigkis; Jeffrey Chapman; Joseph Golish; Demetrios Mermigkis; Kumaraswamy Budur; Antony Kopanakis; Vlassis Polychronopoulos; Richard Burgess; Nancy Foldvary-Schaefer
Journal:  Lung       Date:  2007-04-10       Impact factor: 3.777

4.  Obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: pulmonary hypertension could be the missing link for the diagnosis and different positive airway pressure treatment outcomes.

Authors:  Argyris Tzouvelekis; Athanasios Voulgaris; Paschalis Steiropoulos
Journal:  J Clin Sleep Med       Date:  2021-06-01       Impact factor: 4.324

5.  Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment.

Authors:  George Papadogiannis; Izolde Bouloukaki; Charalampos Mermigkis; Stylianos Michelakis; Christina Ermidou; Eleni Mauroudi; Violeta Moniaki; Nikolaos Tzanakis; Katerina M Antoniou; Sophia E Schiza
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.